Tumors use many strategies to evade the immune system. A new study adds a new trick to the list—inhibiting the migration of dendritic cells from tumors toward lymph nodes (pages 98–105).
References
Villablanca, E.J. et al. Nat. Med. 16, 98–105 (2010).
van Mierlo, G.J.D. et al. J. Immunol. 173, 6753–6759 (2004).
Melief, C.J.M. Immunity 29, 372–383 (2008).
Sica, A. & Bronte, V. J. Clin. Invest. 117, 1155–1166 (2007).
Kortylewski, M. & Yu, H. Curr. Opin. Immunol. 20, 228–233 (2008).
Steinman, R.M. & Banchereau, J. Nature 449, 419–426 (2007).
Bensinger, S.J. & Tontonoz, P. Nature 454, 470–477 (2008).
Bensinger, S.J. et al. Cell 134, 97–111 (2008).
A-Gonzalez, N. Immunity 31, 245–258 (2009).
Nowak, A.K. et al. Adv. Drug Deliv. Rev. 58, 975–990 (2006).
Green, D.R. et al. Nat. Rev. Immunol. 9, 353–363 (2009).
Broomfield, S.A. et al. J. Immunol. 182, 5217–5224 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melief, C. Migration or evasion. Nat Med 16, 35–36 (2010). https://doi.org/10.1038/nm0110-35
Issue Date:
DOI: https://doi.org/10.1038/nm0110-35
- Springer Nature America, Inc.